Inhibition of restraint-induced neuroendocrine and serotonergic responses by buspirone in rats

Pharmacological Reports

Volumn 58, Issue 5, 2006, Pages 636-642

  Samad, Noreen ^a   Perveen, Tahira ^a   Haider, Saida ^a   Haleem, Mohammad A ^b   Haleem, Darakhshan J ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b SIR SYED UNIVERSITY OF ENGINEERING AND TECHNOLOGY   (Pakistan)

Author keywords

Buspirone; HPA axis; Serotonin; Somatodendritic 5 HT1A receptor; Stress

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; BUSPIRONE; CORTICOSTERONE; GLUCOSE; NORADRENALIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; NORADRENALIN BLOOD LEVEL; RAT; SEROTONINERGIC SYSTEM;

EID: 33751001336     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Akyoshi J, Tsuchiyama K, Yamada K, Oba A, Kojima, K, Sasaki I, Nagayama H: Effects of 8-OH-DPAT on corti-costerone after acute and chronic administration of anti-depressants. Prog Neuropsychopharmacol Biol Psychiatry, 1995, 19, 93-103.
2. Bagdy G, Calogero AE, Aulakh CS, Szemeredi K, Murphy DL: Long term cortisol treatment impairs behavioral and neuroendocrine responses to 5-HT1 agonists in, rat. Neuroendocrinology, 1989, 50, 241-247.
3. Cassano WJ JR, D'mello AP: Acute stress-induced facilitation of the hypothalamic-pitutary adrenal axis: evidence for the roles of stressor duration and serotonin. Neuroendocrinology, 2001, 74, 167-177.
4. Chaouloff F: Physiological mechanisms underlying the hypoglycemic effect of 5-HT 1A agonist 8-OH-DPAT: Evidence for peripheral action. Proc Ninth European Conference on Brain Research, les Arcs, 1989.
5. Chaouloff F, Jeanrenaud B: 5 -HT 1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetraline in the conscious rats. J Pharmacol Exp Ther, 1987, 243, 1159-1166.
6. Curzon G: 5-hydroxytryptamine and corticosterone in an animal model of depression. Prog Neuropsychopharmacol Biol Psychiatry, 1989, 13, 305-310.
7. De Boer SF, Slangen JL, Van de Gugten J: Effects of chlordiazepoxide and buspirone on plasma catecholamine and corticosterone levels in rats under basal and stress conditions. Endocrinol Exp, 1990, 24, 229-239.
8. De Boer SF, Slangen JL, Van de Gugten J: Effects of bsupirone and chlordiazepoxide on plasma catecholamine and corticosterone levels in stressed and non-stressed rats. Pharmacol Biochem Behav, 1991, 38, 299-308.
9. Durcan MJ, Wozniak KM, Linnoila M: Modulation of the hypothermic and hyperglycemic effects of 8-OH-DPAT by alpha-2 adrenoceptor antagonists. Br J Pharmacol, 1991, 102, 222-226.
10. Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ: Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin 1A receptors and blockade of alpha2-adrenergic receptors underlie its action. Neuroscience, 1999, 93, 1251-1262.
11. Gur E, Dremencov E, Garcia F, Van de Kar LD, Lerer B, Newman ME: Functional effects of chronic electroconvulsive shock on serotonergic 5-HT 1A and 5-HT 1B receptor activity in rat hippocampus and hypothalamus. Brain Res, 2002, 952, 52-60.
12. Haleem DJ: Repeated corticosterone treatment attenuates behavioral and neuroendocrine responses to 8-hydroxy2-(di-n-propylamino) tetraline in rats. Life Sci, 1992, 51, 225-230.
13. Haleem, DJ: Function specific supersensitivity of m-chlorophenyl piperazine-induced serotonergic neurotransmission in female compared to mate rats. Life Sci, 1993, 52, 279-284.
14. Haleem DJ: Serotonergic mechanism of antidepressant action and adaptation to stress. J Coll Physician Surg Pak, 1999, 9, 139-146.
15. Haleem DJ, Kennett G, Curzon G: Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis. Brain Res, 1988, 458, 339-347.
16. Haleem DJ, Kennett GA, Whitton PS, Curzon G: 8-OH-DPAT increases corticosterone but not other 5-HT 1A receptor-dependent responses more in females. Eur J Pharmacol, 1989, 164, 435-443.
17. Haleem DJ, Perveen T: Brain regional serotonin synthesis following adaptation to repeated restraint. Neuroreport, 1994, 5, 1785-1788.
18. Haleem DJ, Saify ZS, Siddiqui S, Batool F, Haleem MA: Pre- and postsynaptic receptors to 1 -(1-naphthylpiperazine) following adaptation to stress in rats. Prog Neuropsychopharmacol Biol Psychiatry, 2002, 26, 149-156.
19. Haleem DJ, Shireen E, Haleem MA: Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy. Prog Neuropsychopharmacol Biol Psychiatry, 2004, 28, 1323-1329.
20. Haller J, Halasz J: Mild social stress abolishes the effects of isolation on anxiety and chlordiazepoxide reactivity. Psychopharmacology, 1999, 144, 311-315.
21. Kan SF, Kau MM, Ton Ho LL, Wang PS: Inhibitory effects of bromocriptine on corticosterone secretion in male rats. Eur J Pharmacol, 2003, 468, 141-149.
22. Kennett GA, Curzon G, Hunt A, Patel AJ: Immobilization decreases amino acid concentration in plasma but maintains or increases them in the brain. J Neurochem, 1986, 46, 208-212.
23. Khouzam HR, Emes R: The use of buspirone in primary care. J Psychosoc Nurs Ment Health Serv, 2002, 40, 34-41.
24. Korte SM, Smith J, Bouws GA, Koolhaas JM, Bohus B: Behavioral and neuroendocrine responses to psychosocial stress in male rats: the 5-HT 1A agonist ipsapirone. Horm Behav, 1990, 24, 554-567.
25. Leu SF, Chien CH, Tseng CY, Kuo YM, Huang BM: The in vivo effect of Cordyceps sinesis mycelium on plasma corticosterone levels in male mouse. Biol Pharm Bull, 2005, 28, 1722-1725.
26. Lorens SA, Van de Kar LD: Differential effects of serotonin (5-HT-1A and 5-HT-2) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology, 1987, 45, 305-310.
27. Matheson GK, Gage D, White G, Dixon V, Gipson D: A comparison of the effects of buspirone and diazepoxide on plasma corticosterone levels in rats. Neuroendocrinology, 1988, 27, 823-830.
28. Matheson GK, Gage D, White G, Dixon V, Gilthrie D, Rhoades J, Dixon V: The effect of gepirone and 1-(2-pyrimidinyl)-piperazine on levels of corticosterone in rat plasma. Neuropharmacology, 1989, 28, 329-334.
29. Matheson GK, Raess BU, Tunicliff G: Effects of repeated doses of azaspirone on rat brain 5-HT-1A receptors and plasma corticosterone levels. Gen Pharmacol, 1996, 27, 355-361.
30. Matheson GK, Knowles A, Guthrie D, Gage D, Einzapfel D, Blackbourne J: Action of serotonergic agent on hypothalamic-pituitary-adrenal axis activity in the rat. Gen Pharmacol, 1997, 29, 823-828.
31. Mattingly D: A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma. J Clin Pathol, 1962, 15, 165-171.
32. Mattingly D, Martin H, Tyler C: Fluorimetric method for simultaneous estimation of cortisol, corticosterone and testosterone in plasma. J Clin Pathol, 1989, 42, 661-666.
33. Mitchell SN, Thomas PJ: Effects of restraint stress and anxiolytics on 5-HT turnover in rat brain. Pharmacology, 1988, 37, 105-113.
34. Moret C, Briley M: Where are the new therapies for anxiety and obsessive-compulsive disorders? IDrugs, 2001, 4, 1031-1042.
35. Mushtaq F, Haider S, Parveen T, Haleem DJ: Lack of restraint-induced increases of brain serotonin metabolism in rat treated with spiperone: relationship with restraint-induced behavioral deficits. Pak J Pharm Sci, 2004, 17, 57-65.
36. Nishimura H, Tanaka M, Tsuda A, Gondoh Y: Atypical anxiolytic profile of bupirone and a related drug, SM-3997, in a modified forced swim test employing straw suspension. Pharmacol Biochem Behav, 1996, 46, 647-651.
37. Odagaki Y, Toyoshima R, Yamauchi T: Trazodone and its active metabolite m-chlorephenylpiperazine as a partial agonists at 5-HT-1A receptors assessed by [35S] GTP gamma S binding. J Psychopharmacol, 2005, 19, 235-241.
38. Samad N, Parveen T, Haider S, Haleem DJ: Effects of repeated injection of neem leaf extract and restraint stress on a model of anxiety and brain serotonin metabolism in rats. J Hamdard Medicus, 2002, 45, 54-58.
39. Samad N, Parveen T, Haider S, Haleem DJ: Attenuation of restraint induced anorexia and anxiogenic behavior by serotonin-1A agonists in rat. J Med Sci, 2005, 5, 289-293.
40. Samad N, Parveen T, Haider S, Haleem DJ: Attenuation of restraint induced behavioral deficits by buspirone and propranolol in rats. J Coll Physicians Surg Pak, 2005, 15, 795-798.
41. Sugimoto Y, Kimura I, Watanabe Y, Yamada J: The 5-HT-1A receptor agonist 8-hydroxy-2-(di-n-propylamino) tetraline (8-OH-DPAT) induces hyperglucogenomia in rats. Biol Pharm Bull, 2001, 24, 1191-1194.
42. Sugimoto Y, Takashima N. Noma T, Yamada J: Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice. J Pharmacol Sci, 2003, 93, 446-450.
43. Sugimoto Y, Takashima N, Noma T, Yamada J: Inhibitory effects of the 5-HT-1A receptors agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl) piperazine (1-PP). Biol Pharm Bull, 2005, 28, 733-735.
44. Sugimoto Y, Yamada J, Kimura I, Watanabe Y, Horisaka K: The effects of the serotonin-1A receptor agonist buspirone on the blood glucose and pancreatic hormones in rat. Jpn J Pharmacol, 1992, 60, 145-148.
45. Tunnicliff G, Brokaw JJ, Husz JA, Methason GK, White GW: Influences of repeated treatment with buspirone on 5-hydroxy-tryptamine and dopamine synthesis. Neuropharmacology, 1992, 31, 991-995.
46. Van de Kar LD, Raap DK, Battaglia G, Muma NA, Garcia F, Doncarlos LL: Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT-1A receptors with no change in 5-HT-2A receptors. Neuropharmacology, 2002, 43, 45-54.
47. Vander Maelen CP, Taylor DP Gehlibach G, Eison MS: Nonbenzodiazepine anxiolytics: insights into possible mechanisms of action. Psychopharmacol Bull, 1986, 22, 807-812.